Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1410562.RAeWQw97FXIPG5VaubYMfKSxF_Q2DZVj6YdP04O92lpYE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1410562.RAeWQw97FXIPG5VaubYMfKSxF_Q2DZVj6YdP04O92lpYE130_assertion type Assertion NP1410562.RAeWQw97FXIPG5VaubYMfKSxF_Q2DZVj6YdP04O92lpYE130_head.
- NP1410562.RAeWQw97FXIPG5VaubYMfKSxF_Q2DZVj6YdP04O92lpYE130_assertion description "[To clarify this apparent discrepancy, 48 pediatric patients treated on Dana-Farber Cancer Institute (DFCI) protocols with ALL at first or second relapse were tested for TEL/AML1 using reverse transcriptase-polymerase chain reaction (RT-PCR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1410562.RAeWQw97FXIPG5VaubYMfKSxF_Q2DZVj6YdP04O92lpYE130_provenance.
- NP1410562.RAeWQw97FXIPG5VaubYMfKSxF_Q2DZVj6YdP04O92lpYE130_assertion evidence source_evidence_literature NP1410562.RAeWQw97FXIPG5VaubYMfKSxF_Q2DZVj6YdP04O92lpYE130_provenance.
- NP1410562.RAeWQw97FXIPG5VaubYMfKSxF_Q2DZVj6YdP04O92lpYE130_assertion SIO_000772 9845546 NP1410562.RAeWQw97FXIPG5VaubYMfKSxF_Q2DZVj6YdP04O92lpYE130_provenance.
- NP1410562.RAeWQw97FXIPG5VaubYMfKSxF_Q2DZVj6YdP04O92lpYE130_assertion wasDerivedFrom befree-2016 NP1410562.RAeWQw97FXIPG5VaubYMfKSxF_Q2DZVj6YdP04O92lpYE130_provenance.
- NP1410562.RAeWQw97FXIPG5VaubYMfKSxF_Q2DZVj6YdP04O92lpYE130_assertion wasGeneratedBy ECO_0000203 NP1410562.RAeWQw97FXIPG5VaubYMfKSxF_Q2DZVj6YdP04O92lpYE130_provenance.